The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,164.00
Bid: 1,162.00
Ask: 1,166.00
Change: 10.00 (0.87%)
Spread: 4.00 (0.344%)
Open: 1,170.00
High: 1,172.00
Low: 1,146.00
Prev. Close: 1,154.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

12 Jan 2022 07:00

RNS Number : 1290Y
Savills PLC
12 January 2022
 

 

 

12 January 2022

SAVILLS PLC

("Savills" or the "Group")

 

Year-End Trading Statement

 

Full year performance very significantly ahead of expectations - FY22 outlook currently unchanged

 

 

Savills plc, the global real estate advisor, publishes the following trading statement in respect of the year ended 31 December 2021.

 

Since the trading update on 9th November 2021, the Group has experienced an extraordinarily strong final trading period, particularly in the UK and Asia Pacific regions alongside improved performances in Continental Europe and the Middle East ("CEME") and North America; both of which have more than eliminated the losses of 2020. All Savills businesses have exceeded their forecasts notwithstanding the impact of renewed pandemic-related restrictions in many locations. In particular, commercial capital transactions and Prime Residential Agency experienced much stronger completion volumes than previously anticipated. Our Less Transactional businesses have also outperformed their previous expectations.

 

In addition, as previously disclosed, the Group has benefited from substantially lower levels of discretionary expenditure in respect of travel, entertaining and marketing events in particular. These are expected to revert to more normal levels over the course of 2022.

 

As a result of this strong trading performance coupled with the benefit of abnormally low levels of discretionary expenditure, the Group expects Underlying Profit Before Tax ("UPBT") for 2021 to be very significantly ahead of the upper end of its previous range of expectations.

 

Despite the backdrop of pandemic-related uncertainty in 2021, the UK performed exceptionally well across all business lines. There were notably strong performances from the Transactional Business lines, albeit Commercial office leasing volumes remained below historic averages in the majority of markets. Savills' strengths in both logistics and retail warehousing, both of which enjoyed significant volume increases year-on-year, also contributed to our overall outperformance. The UK prime residential market continued to perform exceptionally strongly through the last quarter and volumes in the Prime Central London market clearly began to improve. Currently there is a definite shortage of sale stock, so despite outperformance in 2021, our expectation of a moderation of activity in 2022 remains intact.

 

Our commercial investment activities benefited from significant increases in trading volumes, indeed the last quarter of 2021 saw volumes in EMEA exceed the five year average. This was partly due to an unwinding of pandemic driven delays as capital, which would ordinarily have been invested earlier, but for pandemic-related uncertainty, was increasingly deployed through 2021.

 

Our Asia Pacific business as a whole performed well ahead of our expectations. Hong Kong sales activity and market share remained strong through the period and Australia, Singapore and Japan also enjoyed strong trading activity in the final quarter.

 

Savills Investment Management outperformed its expectations with the benefit of the acquisition of DRC Capital from the end of May in strong markets for real estate debt investment, together with new fund launches and strong investment performance from the majority of our products. The latter in particular gave rise to higher than anticipated performance fees in the final quarter.

 

Looking to the year ahead, the Group's previous expectations remain unchanged at this early stage. Inflationary pressures in many markets will result in employment costs increasing at the highest rate for many years and we anticipate that discretionary costs will progressively normalise. In respect of trading revenues, at this stage, we anticipate some normalisation of commercial capital transaction volumes and a moderation of levels of activity in some residential markets, particularly in the UK.

 

Savills intends to report 2021 full year results on 10 March 2022.

 

This announcement contains inside information. The person responsible for arranging for the release of this announcement on behalf of the Company is Chris Lee, Group Legal Director & Company Secretary.

 

 

 

 

For further information, contact:

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Elizabeth Snow

Mark Burgess

 

Forward looking statements

Certain statements in this announcement are forward-looking statements relating to the Group's operations, performance and financial position based on current expectations of, and assumptions and forecasts made by, management. They are subject to a number of risks, uncertainties and other factors which could cause actual results, performance or achievements of the Group to differ materially from any outcomes or results expressed or implied by such forward-looking statements. The Group's principal risks are described in the 2020 Savills plc Annual Report which can be viewed online at http://www.savills.com. Such forward looking statements should therefore be construed in light of such risks, uncertainties and other factors and undue reliance should not be placed on them. They are made only as of the date of this announcement and no representation, assurance, guarantee or warranty is given in relation to them including as to their accuracy, completeness, or the basis on which they are made. No obligation is accepted to publicly revise or update these forward-looking statements or adjust them as a result of new information or for future events or developments, except to the extent legally required. Nothing in this Statement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSDLRILLIF
Date   Source Headline
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
22nd Jan 20249:11 amRNSBlock listing Interim Review
11th Jan 20244:02 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSYear End Trading Update
2nd Jan 202412:33 pmRNSTotal Voting Rights
15th Dec 202310:00 amRNSAdditional Listing
14th Dec 202312:56 pmRNSDirector/PDMR Shareholding
13th Dec 202311:42 amRNSNon-Executive Director Appointment
13th Nov 20232:02 pmRNSSAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA
13th Nov 202312:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20233:16 pmRNSForm 8.3 - OntheMarket PLC
1st Nov 202310:00 amRNSTotal Voting Rights
27th Oct 202310:00 amRNSAdditional Listing
12th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20238:50 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSAdditional Listing
12th Sep 20235:10 pmRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
18th Aug 20232:00 pmRNSAdditional Listing
15th Aug 20234:06 pmRNSBlock listing Interim Review
14th Aug 20232:05 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSChair Succession
10th Aug 20237:00 amRNSHalf-year Report
21st Jul 202310:00 amRNSBlock listing Interim Review
11th Jul 202312:50 pmRNSDirector/PDMR Shareholding
4th Jul 20239:20 amRNSTotal Voting Rights
13th Jun 20235:31 pmRNSDirector/PDMR Shareholding
1st Jun 202310:00 amRNSTotal Voting Rights
17th May 20234:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
11th May 20236:12 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20235:15 pmRNSDirector/PDMR Shareholding
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:15 pmRNSAnnual Report and AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.